Water, sanitation and hygiene (WASH): the evolution of a global health and development sector.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
04 Oct 2024
Historique:
received: 15 02 2024
accepted: 22 08 2024
medline: 5 10 2024
pubmed: 5 10 2024
entrez: 4 10 2024
Statut: epublish

Résumé

Despite some progress, universal access to safe water, sanitation and hygiene (WASH) by 2030-a remit of Sustainable Development Goal 6-remains a distant prospect in many countries. Policy-makers and implementers of the WASH sector are challenged to track a new path. This research aimed to identify core orienting themes of the sector, as legacies of past processes, which can provide insights for its future. We reviewed global policy, science and programmatic documents and carried out 19 expert interviews to track the evolution of the global WASH sector over seven decades. We situated this evolution in relation to wider trends in global health and development over the same time period.With transnational flows of concern, expertise and resources from high-income to lower-income countries, the WASH sector evolved over decades of international institutionalisation of health and development with (1) a focus on technologies (technicalisation), (2) a search for generalised solutions (universalisation), (3) attempts to make recipients responsible for environmental health (responsibilisation) and (4) the shaping of programmes around quantifiable outcomes (metricisation). The emergent commitment of the WASH sector to these core themes reflects a pragmatic response in health and development to depoliticise poverty and social inequalities in order to enable action. This leads to questions about what potential solutions have been obscured, a recognition which might be understood as 'uncomfortable knowledge'-the knowns that have had to be unknown, which resonate with concerns about deep inequalities, shrinking budgets and the gap between what could and has been achieved.

Identifiants

pubmed: 39366708
pii: bmjgh-2024-015367
doi: 10.1136/bmjgh-2024-015367
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Sara de Wit (S)

Institute for History, Leiden University, Leiden, The Netherlands.

Euphrasia Luseka (E)

Freelance, Nairobi, Kenya.

David Bradley (D)

Department of Zoology, University of Oxford, Oxford, UK.
Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.

Joe Brown (J)

Environmental Science and Engineering, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.

Jayant Bhagwan (J)

WaterUse, Wastewater Resources and Sanitation Future, Water Research Commission, Lynnwood Manor, South Africa.

Barbara Evans (B)

Public Health Engineering, University of Leeds, Leeds, UK.

Matthew C Freeman (MC)

Gangarosa Department of Environmental Health, Emory Univ, Atlanta, Georgia, USA.

Guy Howard (G)

University of Bristol, Bristol, UK.

Isha Ray (I)

Energy & Resources Group, UC Berkeley, Berkeley, California, USA.

Ian Ross (I)

Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.

Sheillah Simiyu (S)

African Population and Health Research Center, Nairobi, Kenya.

Oliver Cumming (O)

Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.

Clare I R Chandler (CIR)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK clare.chandler@lshtm.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH